- Features of changes in the vaginal microbiota of women of fertile age as a possible mechanism for the occurrence of chronic inflammatory diseases of the genital organs and modern correction possibilities
Features of changes in the vaginal microbiota of women of fertile age as a possible mechanism for the occurrence of chronic inflammatory diseases of the genital organs and modern correction possibilities
HEALTH OF WOMAN. 2020.2(148): 60–64; doi 10.15574/HW.2020.148.60
Podolskyi Vl. V., Podolskyi V. V.
Institute of pediatrics, obstetrics and ginecology NAMS of Ukraine
The article presents the data of the review of literature sources, concerning the peculiarities of microbiota functioning of organs of reproductive system of women of fertile age, in the aspect of formation and functioning of biological films by pathogenic and conditionally pathogenic microflora. The role of infectious, more often microbial factor in the genesis of inflammatory diseases of the pelvic organs in women can not always be represented only in the form of simple causal structural and functional relationships against the background of post-aggressive metabolic response. Its importance may change even as complications develop. Microbial colonization of the genitals against the background of impaired vaginal microbiocenosis can be an early stage of the infectious process and have a detrimental effect on reproductive health. In healthy women of fertile age, the content of vaginal mucus has an acid reaction (pH=4.0–4.7) due to the high concentration of lactic acid (2.0–3.0%), which is formed during the metabolism of lactobacilli and the presence of hydrogen peroxide. In diseases there is a disturbance of equilibrium in this system. The shift of pH towards the alkaline reaction causes the growth of conditionally pathogenic flora, especially anaerobes. The decrease in the number of lactic acid bacteria enables the growth of titers of opportunistic microflora. Upon reaching the pathogenic microflora of critical titers, it becomes pathogenic and attacks the cells of the host organism. It is also important to note that antagonism between lactic acid bacteria and conditionally pathogenic microflora does not occur, or does not occur frequently, without a dramatic change in homeostasis. Administration of local probiotics in combination with lactic acid after the repair of the vagina significantly reduces the risk of recurrent inflammatory process caused by resident conditionally pathogenic microflora, maintaining the required pH level, and the use of lactic acid bacteria, which have sufficient opportunities for adhesion to cell surfaces and biological pathological conditions of microorganisms.
Key words: microbiocenosis, chronic inflammatory diseases of the genital organs, pelvic inflammatory diseases, women of fertile age, opportunistic flora, lactic acid, lactic acid bacteria.
REFERENCES
1. Podolskyi VV, Dronova VL, Teterin VV, Podolskyi VlV, Yusko TI. 2012. Alhorytm obstezhennia zhinok z khronichnymy zapalnymy zakhvoriuvanniamy statevykh orhaniv, napravlenyi na profilaktyku perynatalnykh porushen. Aktualni pytannia po akusherstvu ta hinekolohii 2:27–29.
2. Podolskyi VV. 2002. Khronichni zapalni zakhvoriuvannia statevykh orhaniv. Zdorovia zhinky v Ukraini 1(18):54–55.
3. Podolskyi VlV. 2013. Profilaktyka ta prohnozuvannia akusherskykh i perynatalnykh porushen u zhinok, shcho perenesly khronichni zapalni zakhvoriuvannia statevykh orhaniv. Zhurnal natsionalnoi akademii medychnykh nauk Ukrainy 19;Dodatok:109–110.
4. Ventskivska IB, Podolskyi VlV. Stan mikrobiotsenozu urohenitalnykh orhaniv u zhinok fertylnoho viku, shcho perenesly khronichni zapalni zakhvoriuvannia statevykh orhaniv. Naukovyi visnyk Natsionalnoho medychnoho universytetu imeni O.O. Bohomoltsia. Materialy mizhnarodnoi naukovo-praktychnoi konferentsii. 7–8 kvitnia 2008: 54–55.
5. Dubchak AE, Lysianaia TA, Mylevskyi AV. 2010. Vosstanovlenye mykrobyotsenoza vlahalyshcha u zhenshchyn s khronycheskym kandydoznыm vahynytom y polymykrobnoi ynfektsyei. Zdorove zhenshchynы 8:102–104.
6. Kaminskyi VV, Markin LB ta in. 2008. Zberezhennia reproduktyvnoho zdorovia zhinky – osnova formuvannia zdorovoi natsii. Zdorovia Ukrainy 9:58–59.
7.Dolgushin II, Chernyih SL, Dolgushina VF. 2001. Gormonalnaya korrektsiya rezidentnoy mikrofloryi vlagalischa i sheyki matki u zhenschin s hronicheskimi tservitsitami. Zhurn. mikrobiol., epidemiol. i immunobiologii 4:100–104.
8. Martín R, Sánchez B, Suárez JE, Urdaci MC. 2012. Characterization of the adherence properties of human Lactobacilli strains to be used as vaginal probiotics. FEMS Microbiology Letters. 328(2):166–73. https://doi.org/10.1111/j.1574-6968.2011.02495.x; PMid:22224921
9. Boris S, Suarez JE, Vázquez F, Barbés C. 1998. Adherence of human vaginal lactobacilli to vaginal epithelial cells and interaction with uropathogens. Infect Immun 66:1985–1989. https://doi.org/10.1128/IAI.66.5.1985-1989.1998: PMid:9573080 PMCid:PMC108154
10. Osset J, Bartolomé RM, García E. 2001. Assessment of the capacity of Lactobacillus to inhibit the growth of uropathogens and block their adhesion to vaginal epithelial cells. J Infect Dis 183:485–491. https://doi.org/10.1086/318070; PMid:11133381
11. Boskey ER, Cone RA, Whaley KJ & Moench TR. 2001. Origins of vaginal acidity: high D/L lactate ratio is consistent with bacteria being the primary source. Hum Reprod 16:1809–1813. https://doi.org/10.1093/humrep/16.9.1809; PMid:11527880
12. Motevaseli E, Shirzad M, Raoofian R, Hasheminasab S-M, Hatami M, Dianatpour M et al. 2013. Differences in vaginal lactobacilli composition of Iranian healthy and bacterial vaginosis infected women: a comparative analysis of their cytotoxic effects with commercial vaginal probiotics. Iranian Red Crescent medical journal 15(3):199–206. https://doi.org/10.5812/ircmj.3533; PMid:23983998 PMCid:PMC3745747
13. Pendharkar S, Institutionen för Laboratoriemedicin. Lactobacillus based treatment of vaginal infections.
14. Anukam KC, Osazuwa EO, Ahonkhai I, Reid G. 2005. 16S rRNA gene sequence and phylogenetic tree of lactobacillus species from the vagina of healthy Nigerian women. African Journal of biotechnology 4(11).
15. Schwiertz A. 2016. Microbiota of the human body: implications in health and disease. https://doi.org/10.1007/978-3-319-31248-4
16. Spencer JFT, Ragout de Spencer AL. 2004. Public health microbiology methods and protocols. Totowa, NJ. Oxford, Humana; Blackwell.
